Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 13;16(1):114.
doi: 10.1186/s12876-016-0530-4.

Prevalence of medication discrepancies in patients with cirrhosis: a pilot study

Affiliations

Prevalence of medication discrepancies in patients with cirrhosis: a pilot study

Kelly L Hayward et al. BMC Gastroenterol. .

Abstract

Background: Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities. Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management. The aim of the present study was to assess the magnitude and types of discrepancies among patient-reported and medical record-documented medications in patients with cirrhosis, and examine factors associated with such discrepancies.

Methods: Fifty patients who attended a hospital hepatology outpatient clinic were interviewed using a questionnaire composed of mixed short-response and multiple-choice questions. Patients' reported medication use was compared with documentation in the hospital medical records and pharmacy database. Medication adherence was assessed using the 8-question ©Morisky Medication Adherence Scale (MMAS-8). The multivariate logistic regression model was constructed using clinically relevant and/or statistically significant variables as determined by univariate analysis. All p-values were 2-sided (α = 0.05).

Results: Twenty-seven patients (54.0 %) had ≥1 discrepancy between reported and documented medicines. Patients with ≥1 discrepancy were older (p = 0.04) and multivariate analysis identified taking ≥5 conventional medicines or having a 'low' or 'medium' adherence ranking as independent predictors of discrepancy (adjusted OR 11.0 (95 % CI 1.8-67.4), 20.7 (95 % CI 1.3-337.7) and 49.0 (95 % CI 3.3-718.5) respectively). Concordance was highest for liver disease medicines (71.9 %) and lowest for complementary and alternative medicines (14.5 %) and respiratory medicines (0 %).

Conclusion: There is significant discrepancy between sources of patient medication information within the hepatology clinic. Medication reconciliation and medicines-management intervention may address the complex relationship between medication discrepancies, number of medications and patient adherence identified in this study.

Keywords: Ambulatory care; Complementary therapies; Liver cirrhosis; Medication adherence; Medication reconciliation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Number of discrepancies between patient-reported conventional medications (including prescribed CAMs) and their medical record
Fig. 2
Fig. 2
Venn distribution of medications reported by patients, documented in their medical records and recorded in ELMs. Overlap represents medications that were concordant between sources. Total number of medications = 307 (n = 63 CAMS; n = 244 conventional medicines)
Fig. 3
Fig. 3
a. Concordance between medications reported by the patient and documented in their medical record with respect to drug-disease category. Patients (n = 50) taking ≥1 medication in drug-disease class: liver n = 28; CAMs n = 28; cardiovascular n = 22; diabetes n = 14; psychomodulators n = 13; analgesia n = 17; other n = 14; gastro-luminal n = 10; respiratory n = 5. b. Concordance between medications recorded in ELMs and documented in the medical record with respect to drug-disease category. Patients (n = 16) taking ≥1 medication in drug-disease class: liver n = 11; CAMs n = 10; cardiovascular n = 7; diabetes n = 5; psychomodulators n = 3; analgesia n = 5; other n = 5; gastro-luminal n = 5; respiratory n = 4

References

    1. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12:145. doi: 10.1186/s12916-014-0145-y. - DOI - PMC - PubMed
    1. Zipprich A, Garcia-Tsao G, Rogowski S, Fleig W, Seufferlein T, Dollinger M. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012;32:1407–14. doi: 10.1111/j.1478-3231.2012.02830.x. - DOI - PMC - PubMed
    1. Fagan KJ, Zhao EY, Horsfall LU, Ruffin BJ, Kruger MS, McPhail SM, et al. Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change? Intern Med J. 2014;44:865–72. doi: 10.1111/imj.12491. - DOI - PubMed
    1. Deloitte Access Economics . The economic cost and health burden of liver diseases in Australia. Kingston: The Gastroenterological Society of Australia/Australian Liver Association; 2013.
    1. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247–52. doi: 10.1038/ajg.2011.314. - DOI - PMC - PubMed